James B. Jones

Biography

James B. Jones joined Pacira as Senior Vice President and Chief Medical Officer in 2015. He is primarily responsible for overseeing and guiding the Company’s clinical research and development efforts for the expanded uses of EXPAREL® and the Company’s DepoFoam® pipeline of products. Dr. Jones has worked on various analgesics, such as nonsteroidal anti-inflammatory drugs (NSAIDs), and CNS compounds throughout his career. He was most recently vice president at The Medicines Company, where he was responsible for the submission and approval of IONSYS® (fentanyl iontophoretic transdermal system) in the United States and for directing the delivery system’s application and submission process in the European Union. Previously, he was chief medical officer at Cara Therapeutics, where he oversaw the Phase 2 clinical development of the lead product candidate CR845, a peripherally-restricted kappa opioid agonist. Dr. Jones is a practicing Board Certified Emergency Medicine physician, having received his Doctorate of Medicine degree from the University of Pennsylvania and his Bachelor of Science and Doctorate of Pharmacy degrees from Purdue University. 

Research Interest

 analgesics, such as nonsteroidal anti-inflammatory drugs (NSAIDs), and CNS compounds